Nishimura T, Aze Y, Ozeki Y
Safety Research Laboratories, Fukui Research Institute, Ono Pharmaceutical Co., Ltd., Japan.
J Toxicol Sci. 1995 Aug;20(3):341-9. doi: 10.2131/jts.20.341.
To determine an appropriate administration period and sensitive end-points for the evaluation of effects on male fertility, male Sprague-Dawley rats were orally given nitrofurazone, a model compound, at doses of 12.5, 25, or 50 mg/kg/day for 4 weeks, or at doses of 12.5 or 25 mg/kg/day for 9 weeks before mating with untreated females. Copulation and fertility indices were decreased, and pregnancy did not result at doses of 25 mg/kg/day and over with both dosing periods. An increase in preimplantation loss, and decreases in implants and live fetuses were observed with 12.5 mg/kg/day after 9-weeks dosing. However, no reproductive endpoints were affected by the same dose level for 4-weeks. Sperm head count was reduced at doses of 25 mg/kg/day and over with both dosing periods. Histopathology revealed tubular degeneration and interstitial cell hyperplasia at doses of 25 mg/kg/day and over after both periods of dosing. Moreover, failure of spermiation in tubular epithelia was also detected in the 12.5 mg/kg groups. These results suggest that 4-weeks premating exposure is sufficient for evaluation of the effects of nitrofurazone on mate fertility, and the most sensitive endpoint in this 4-week premating-dose study is a histopathological change.
为确定评估对雄性生育力影响的合适给药期和敏感终点,将雄性斯普拉格-道利大鼠作为实验对象,口服给予模型化合物呋喃西林,剂量分别为12.5、25或50mg/kg/天,持续4周;或在与未处理的雌性大鼠交配前,以12.5或25mg/kg/天的剂量给药9周。交配和生育指数降低,在两个给药期内,剂量为25mg/kg/天及以上时均未导致怀孕。给药9周后,12.5mg/kg/天剂量组观察到着床前损失增加,着床数和活胎数减少。然而,相同剂量水平给药4周时,未观察到对任何生殖终点产生影响。两个给药期内,剂量为25mg/kg/天及以上时精子头计数减少。组织病理学检查显示,两个给药期后,剂量为25mg/kg/天及以上时均出现肾小管变性和间质细胞增生。此外,在12.5mg/kg组中还检测到肾小管上皮细胞精子形成失败。这些结果表明,交配前4周的暴露足以评估呋喃西林对配偶生育力的影响,在这个4周交配前剂量研究中,最敏感的终点是组织病理学变化。